George Soros’s Legend Biotech LEGN Stock Holding History

George Soros’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-90,000	Closed	-$6.05M	–	246
2023 Q3	$6.05M	Buy	+90,000	New	+$6.25M	0.09%	147

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

George Soros's LEGN Position: Q4 2023 in Review

George Soros sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 90,000 shares — an estimated $6.05M sold.

George Soros first reported a position in LEGN in Q3 2023 and held it in 1 quarter. The position peaked at $6.05M in Q3 2023. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

George Soros reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
George Soros sold 90,000 Legend Biotech shares in Q4 2023, an estimated $6.05M.
George Soros first reported a position in Legend Biotech in Q3 2023 and held it in 1 quarter.
George Soros's Legend Biotech position peaked at $6.05M in Q3 2023.
206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Soros Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.